ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Savara Inc

Savara Inc (SVRA)

5,385
0,125
( 2,38% )
Aktualisiert: 20:36:36

Savara Inc (SVRA) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
5,385
( 2,38% )
Gebot
5,38
Fragen
5,39
Volumen
702.619
5,36 Tagesbereich 5,525
1,98 52-Wochen-Bereich 7,005
Marktkapitalisierung
Handelsende
5,26
Handelsbeginn
5,37
Letzte Trade
1
@
5.39
Letzter Handelszeitpunkt
20:37:49
Finanzvolumen
US$ 3.813.140
VWAP
5,427
Durchschnittliches Volumen (3 Mio.)
US$ 1.568.911
Ausgegebene Aktien
253.600.145
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-9,41
Gewinn pro Aktie (EPS)
-0,56
Erlöse (LTM)
-
Nettogewinn (LTM)
-129,48M

Über Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune... Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Langhorne, United States
Gegründet
2026
Savara Inc is listed in the Healthcare sector of the NASDAQ with ticker SVRA. The last closing price for Savara was US$5,26. Over the last year, Savara shares have traded in a share price range of US$ 1,98 to US$ 7,005.

Savara currently has 253.600.145 shares in issue. The market capitalisation of Savara is US$1,37 billion. Savara has a price to earnings ratio (PE ratio) of -9.41.

SVRA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.2154.15860735015.175.5254.7317608735.08550278CS
40.3356.633663366345.055.5254.69515488905.10539238CS
120.1853.557692307695.26.244.69513788005.25666185CS
26-1.495-21.72965116286.886.914.69517413065.59939985CS
523.175143.6651583712.217.0051.9817241444.82847525CS
1562.18568.281253.27.0051.8913020484.19212521CS
2603.495184.9206349211.897.0051.028859163.88125837CS

SVRA - Frequently Asked Questions (FAQ)

What is the current Savara Inc share price?
The current share price of Savara Inc is US$ 5,385
How many Savara Inc shares are in issue?
Savara Inc has 253.600.145 shares in issue
What is the market cap of Savara Inc?
The market capitalisation of Savara Inc is USD 1,37B
What is the 1 year trading range for Savara Inc share price?
Savara Inc has traded in the range of US$ 1,98 to US$ 7,005 during the past year
What is the PE ratio of Savara Inc?
The price to earnings ratio of Savara Inc is -9,41
What is the registered address of Savara Inc?
The registered address for Savara Inc is 1717 Langhorne Newtown Road, Langhorne, Pennsylvania, 19047
What is the Savara Inc website address?
The website address for Savara Inc is www.savarapharma.com
Which industry sector does Savara Inc operate in?
Savara Inc operates in the Biotechnology & Life Sciences sector

SVRA Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen